Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
10/29/1996 | CA2175115A1 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same |
10/29/1996 | CA2053863C Pyridazinone derivatives |
10/24/1996 | WO1996033196A1 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists |
10/24/1996 | WO1996033169A1 1-[φ-(3,4-DIHYDRO-2-NAPHTHALENYL)ALKYL] CYCLIC AMINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION CONTAINING THE SAME |
10/24/1996 | WO1996029315A3 Imidazole derivatives as histamine receptor h3 (ant)agonists |
10/24/1996 | WO1996017953A3 Genetic basis of factor xiii activity |
10/24/1996 | CA2218330A1 1- .omega.-(3,4-dihydro-2-naphthalenyl)alkyl -cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same |
10/24/1996 | CA2218020A1 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists |
10/23/1996 | EP0738323A1 Thrombopoietin |
10/23/1996 | EP0738156A1 Methods and compositions for inhibiting thrombogenesis |
10/23/1996 | EP0738150A1 Bicyclic fibrinogen antagonists |
10/23/1996 | EP0422125B1 Platelet blocking peptides |
10/23/1996 | CN1134151A Pyrazine carboxamide derivs., their production and their use in medicaments |
10/23/1996 | CN1134148A Antithrombotic amidinophenylalanine and amidinopyridylalanine derivs |
10/23/1996 | CN1134146A Benzoyl guanidines, their production and their use in medicaments |
10/23/1996 | CN1133843A Thienopyridone |
10/22/1996 | US5567814 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
10/22/1996 | US5567722 Diuretics |
10/22/1996 | US5567711 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists |
10/17/1996 | WO1996032415A1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues |
10/17/1996 | WO1996032110A1 Thrombin inhibitors |
10/17/1996 | CA2217682A1 Thrombin inhibitors |
10/17/1996 | CA2216996A1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues |
10/16/1996 | EP0737207A1 Inhibitors of human plasmin derived from the kunitz domains |
10/16/1996 | EP0737195A1 New ginkgolide derivatives and a process for preparing them |
10/16/1996 | EP0737193A1 Pyrazolopyridine adenosine antagonists |
10/16/1996 | CN1133289A Substituted 4-phenyl thiazole derivant, preparation and medicine compositions thereof |
10/16/1996 | CN1133189A Oral liquid for body building up |
10/16/1996 | CN1133173A Preparation of diuretic by using neuropsychic tension antagonist |
10/16/1996 | CN1033029C Prepn. of indenoindole compound |
10/15/1996 | US5565471 Method for inhibiting thrombosis |
10/15/1996 | US5565427 Stabilized factor VIII preparations |
10/15/1996 | US5565426 Anti-aggregation, inhibtion of blood clotting |
10/15/1996 | CA2111092C Specifically beta-beta cross-linked hemoglobins and method of preparation |
10/15/1996 | CA2067498C Composition for inducing granulocyte production or b cell production in peripheral blood |
10/15/1996 | CA2040969C Repopulation of macrophages and granulocytes using transforming growth factor-beta |
10/10/1996 | WO1996031598A1 Tie-2 ligands, methods of making and uses thereof |
10/10/1996 | WO1996031533A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same |
10/10/1996 | WO1996031511A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES |
10/10/1996 | WO1996031504A1 Thrombin inhibitors |
10/10/1996 | WO1996031219A1 Inhibition of c. difficile infections by indigestible oligosaccharides |
10/10/1996 | WO1996031129A1 Therapeutic food composition and method to diminish blood sugar fluctuations |
10/10/1996 | WO1996023771A3 Platelet aggregation inhibitors |
10/10/1996 | CA2216859A1 Thrombin inhibitors |
10/10/1996 | CA2216599A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same |
10/10/1996 | CA2215469A1 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
10/09/1996 | EP0736008A1 Indole derivatives as anti-estrogens |
10/09/1996 | EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g) |
10/09/1996 | EP0517740B1 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
10/09/1996 | CN1133050A Composition and methods using nitroxides to avoid oxygen toxicity |
10/09/1996 | CN1133047A Therapeutic peptide derivatives |
10/08/1996 | US5563268 Heterobiaryl derivatives |
10/08/1996 | US5563146 Administering rapamycin |
10/08/1996 | US5563144 Antiserotonins, their preparation and pharmaceutical compositions containing them |
10/08/1996 | US5563141 Heterocyclic compounds |
10/08/1996 | US5563123 Chimeric proteins |
10/08/1996 | US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same |
10/03/1996 | WO1996030532A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
10/03/1996 | WO1996030339A1 Pyrrolidinyl hydroxamic acid compounds and their production process |
10/03/1996 | WO1996030035A1 β-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS |
10/03/1996 | WO1996030031A1 Isolated stromal cells and methods of using the same |
10/03/1996 | WO1996030029A1 Pharmaceutical composition containing selected lanthanum carbonate hydrates |
10/03/1996 | WO1996029989A1 Stable protein:phospholipid compositions and methods____________ |
10/03/1996 | WO1996029973A2 Compositions and methods for inhibiting thrombogenesis |
10/03/1996 | CA2216445A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
10/03/1996 | CA2215720A1 .beta.-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
10/03/1996 | CA2215143A1 Isolated stromal cells and methods of using the same |
10/02/1996 | EP0734721A2 Method of incorporating drugs into a polymer component of stents |
10/02/1996 | EP0734436A1 Inhibition of dna methyltransferase |
10/02/1996 | EP0734386A1 Platelet activating factor antagonists: imidazopyridine indoles |
10/02/1996 | EP0734376A1 Vitamin d amine and amide derivatives |
10/02/1996 | EP0734373A1 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them |
10/02/1996 | EP0734251A1 Method of transmitting a biologically active material to a cell |
10/02/1996 | EP0275285B1 Biodegradable superparamagnetic materials used in clinical applications |
10/02/1996 | CN1132527A G-CSF analogue compsn. and its prepn. method |
10/02/1996 | CN1132201A Adhesion receptor antagonists |
10/02/1996 | CN1132085A Method for prepn. of a medicine for treatment of aplastic anemia |
10/02/1996 | CN1132081A Medicine for treatment of strip scleroma of thrombus phlebitis |
10/01/1996 | US5561148 Oxazolidine derivative |
10/01/1996 | US5561146 Modified guanidino and amidino thrombin inhibitors |
10/01/1996 | US5561144 (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
10/01/1996 | US5561138 Administering rapamycin by mouth, injection, nose, bronchi, skin or rectum; treating autoimmune hemolytic (warm or cold), transient drug induced, alloimmune or aplastic anemia |
10/01/1996 | US5561112 Pseudopeptide isosteres of gly-asp and their use as antithrombic agents |
10/01/1996 | US5560935 Administering to inhibit plasma kallikrein production: improves peripheral blood flow, exhibits analgesic, antiinflammatory and antiallergic properties |
10/01/1996 | CA1338625C Tricyclic compounds |
09/26/1996 | WO1996029411A1 Protein production and delivery |
09/26/1996 | WO1996029347A1 Thrombin inhibitors based on the amino acid sequence of hirudin |
09/26/1996 | WO1996029346A1 Stable polymerized hemoglobin blood-substitute |
09/26/1996 | WO1996029339A1 Fucopeptides |
09/26/1996 | WO1996029327A1 Trypsin and thrombin inhibitors |
09/26/1996 | WO1996029315A2 Imidazole derivatives as histamine receptor h3 (ant)agonists |
09/26/1996 | WO1996029309A1 N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS |
09/26/1996 | WO1996024372A3 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic |
09/26/1996 | CA2215702A1 Thrombin inhibitors based on the amino acid sequence of hirudin |
09/26/1996 | CA2215618A1 Protein production and delivery |
09/26/1996 | CA2215106A1 N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein iib/iiia antagonists and fibrinogen-blood platelets binding inhibitors |
09/26/1996 | CA2214107A1 Fucopeptides |
09/26/1996 | CA2190865A1 Imidazole derivatives as histamine receptor h3 (ant)agonists |
09/25/1996 | EP0733702A1 Stable transglutaminase preparations and process for their preparation |
09/25/1996 | EP0733642A1 Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivatives, their preparation and their pharmaceutical compositions |